Press release
U.S. Ketamine Clinics Market: Key Players and Competitive Landscape 2023-2028
IMARC Group, a leading market research company, has recently releases report titled "U.S. Ketamine Clinics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the U.S. ketamine clinics market growth, trends, size, share and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.How Big Is the U.S. Ketamine Clinics Market?
The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022 and is expected to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.
Request for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample
What are Ketamine Clinics?
Ketamine clinics are medical facilities that specialize in the administration of ketamine, a dissociative anesthetic, for therapeutic purposes. They offer a novel and rapidly effective treatment option for individuals who have not responded to traditional antidepressant medications. They are managed by medical professionals who are well-versed in administering the medication safely and monitoring patients during and after treatment, which ensures a high level of safety and reduces the risk of adverse effects. As they offer a convenient and safe environment while providing relief from various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD), the demand for ketamine clinics is rising in the U.S.
U.S. Ketamine Clinics Market Trends and Drivers:
At present, the growing demand for ketamine due to its effectiveness in providing rapid relief for treatment-resistant depression and other mental health conditions represents one of the key factors offering a favorable market outlook in the U.S. Besides this, the increasing demand for ketamine, as it produces noticeable improvements within hours or days compared to the slower response of traditional antidepressant medications, is propelling the growth of the market. In addition, the rising mental health awareness is leading to the growing demand for innovative treatment options. Ketamine clinics, with their potential to address conditions like depression, anxiety, and PTSD, are providing solutions to the mental health crisis in the country. In line with this, ongoing research and clinical trials are validating therapeutic benefits of ketamine. As a result, healthcare professionals in the U.S. are becoming increasingly interested in incorporating ketamine treatments into their practices. Moreover, the rising number of people who do not respond well to traditional psychiatric medications is catalyzing the demand for ketamine treatment that offers benefits to those with treatment-resistant conditions. Additionally, the increasing awareness among the masses about the benefits of ketamine treatment is offering lucrative growth opportunities to industry investors operating in the U.S.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Treatment:
• Depression
• Anxiety
• PTSD
• Others
Breakup by Therapy:
• On-Site Therapy
• Online Therapy
Breakup by Region:
• Northeast
• Midwest
• South
• West
The report provides a comprehensive analysis of the industry key players listed below:
• Better U LLC
• Field Trip Health and Wellness Ltd.
• Innerwell
• Ketamine Clinics Los Angeles
• Klarisana - Ketamine Treatment Austin
• Klarity Clinic
• Mindbloom Inc.
• Nue Life Health PBC
• NY Ketamine Infusions
• Vitalitas Denver
Key highlights of the Report:
Market Performance (2018-2023)
Market Outlook (2023-2028)
COVID-19 Impact on the Market
Porter's Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
TOC for the Report:
Preface
Scope and Methodology
Executive Summary
Introduction
SWOT Analysis
Value Chain Analysis
Price Analysis
Competitive Landscape
Explore More Reports:
India Pet Food Market Report: https://www.imarcgroup.com/india-pet-food-market
India Private Equity Market Report: https://www.imarcgroup.com/india-private-equity-market
India Rice Market Report: https://www.imarcgroup.com/india-rice-market
India Security Market Report: https://www.imarcgroup.com/india-security-market
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Ketamine Clinics Market: Key Players and Competitive Landscape 2023-2028 here
News-ID: 3306669 • Views: …
More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview
Market Size in 2024: USD 266.2 Million
Market Size in 2033: USD 422.9 Million
Market Growth Rate 2025-2033: 5.3%
According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a…

GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview
Market Size in 2024: USD 73.31 Billion
Market Size in 2033: USD 147.77 Billion
Market Growth Rate 2025-2033: 7.50%
According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by…

GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview
Market Size in 2024: USD 588.2 Million
Market Size in 2033: USD 2,005.3 Million
Market Growth Rate 2025-2033: 13.3%
According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of…

Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview:
The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach…
More Releases for Ketamine
Helloinnerwell Unveils the Transformative Benefits of Ketamine for Mental Health …
Depression and anxiety remain major barriersto fulfillment for millions around the world. Traditional antidepressants may take weeks to months to have an effect, and many experience disastrous results, no results, or side effectsthat we do not want.
But a new, scientifically backed treatmentnow exists that can bring you jarred relief, potentially fast and it uses a very interesting, and run-of-the-mill drug online therapy [https://helloinnerwell.com/] of ketamine.
Compared to traditional medications, ketamine provides…
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it…
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…